A Short Review on Recent Advances in Coagulation Sensors for COVID-19 Disease Management
Journal: International Journal of Science and Research (IJSR) (Vol.10, No. 12)Publication Date: 2021-12-05
Authors : Navin Pai; Atul Sharma; Rupesh Kumar Mishra;
Page : 341-349
Keywords : Biosensors; SARS-CoV-2; COVID-19; Point of care device;
Abstract
The COVID-19 disease caused by severe acute respiratory syndrome by the coronavirus-2 (SARS-CoV-2) has affected multiple world regions. COVID-19-induced coagulopathy (CIC) is characterized by a significant increase in D-dimer and fibrin split products and increases in activated partial thromboplastin and prothrombin time seen upon presentation. Biosensors are analytical tools that can provide fast, accurate, and reliable platforms for detecting viruses. This present review emphasizes an overview of the latest progress in biosensor-based diagnosis biomarkers of CIC.
Other Latest Articles
- Employers' Feedbacks on the Performances of the Criminology Graduates of Isabela State University Cabagan
- Influencing Factors on Mycobacterium tuberculosis that Causes Tuberculosis (TB) in Benghazi: Environmental and Behavioral Factors
- The Discourse of Annie Wilkes in the Film Misery 1987
- Influence of Self-Esteem, Locus of Control and Parenting Styles on Coping Styles of Students
- Perceptions of Secularism in India
Last modified: 2022-02-15 18:57:28